Latest Cash Flow News

Australian Foundation Investment Company Limited (AFIC) has announced a fully franked dividend of AUD 0.12 per share for the half-year ending December 2024, accompanied by Dividend Reinvestment and Bonus Security Plans.

Range International Limited delivered a standout Q4 2024 with record sales revenue from its Re>Pal Indonesia operations, alongside improved margins and positive cash flow, signaling a robust turnaround.

Spectur Limited reported a robust net cash inflow from operating activities of $2.53 million in Q4 2024, offsetting modest outflows in investing and financing activities. The company closed the quarter with $869,000 in cash and cash equivalents, signaling operational resilience in the surveillance technology sector.

Spectur Limited reports a steady increase in revenue and positive operating cash flow for Q2 FY25, signaling progress in its strategic shift towards profitability. Cost-cutting initiatives and recurring revenue growth underpin expectations for consistent profits in the coming quarters.

29Metals has formalized a key refinancing deal that reduces near-term debt repayments by US$74 million and extends facility maturities to 2028, positioning the company for enhanced liquidity and strategic investment in its Gossan Valley project.

Pantoro Limited delivered a solid December quarter with gold production within guidance and positive cash flows for the fourth consecutive quarter, prompting an upward revision to its FY2025 production target. The company’s strategic focus on underground expansion and asset optimisation underpins its growth trajectory.

Beach Energy delivered a robust Q2 FY25 with a 22% production increase and a 32% surge in sales revenue, driven by LNG sales and operational efficiencies. The company also significantly reduced net debt while advancing key projects like the Waitsia Gas Plant and Moomba CCS.

Invex Therapeutics reports encouraging results from its collaboration with Tessara Therapeutics, showing Exenatide’s potential to improve neuronal survival in a 3D human brain model of Alzheimer's disease. The company maintains a stable cash position while exploring new neurological partnerships.

Woodside Energy achieved record annual production in 2024, led by the Sangomar project, while advancing key LNG developments and streamlining its asset portfolio through a major swap with Chevron.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

Metals X Limited has delivered a record-breaking quarter with tin production hitting 3,329 tonnes, alongside a significant boost in revenue and cash reserves. The company also advanced its strategic positioning through an increased stake in First Tin Plc and an unsolicited acquisition approach to Greentech Technology International.

Evolution Mining delivered a standout December quarter with record cash flows, improved safety, and regulatory approval extending Cowal’s mine life to 2042. The company’s growth projects, including the Mungari mill expansion, are progressing ahead of schedule and under budget, positioning Evolution strongly for FY25.